SARC044: A Phase II Trial of Bezuclastinib in Combination With Sunitinib in Patients With GIST
Conditions: Gastrointestinal Stromal Tumors; GIST Interventions: Drug: Bezuclastinib in combination with sunitinib Sponsors: Sarcoma Alliance for Research through Collaboration; Cogent Biosciences, Inc.; Dana-Farber Cancer Institute; The Life Raft Group Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Gastroenterology | Gastrointestinal Stromal Tumor (GIST) | Research | Sarcomas